Literature DB >> 21837444

Neurocognitive impact of antiretroviral treatment: thinking long-term.

Megan E McPhail1, Kevin R Robertson.   

Abstract

Combination antiretroviral therapy has significantly reduced morbidity and mortality with HIV infection. However, HIV-associated neurocognitive disorders persist at a relatively high prevalence rate despite successful systemic treatment. This paper reviews the current issues related to the neurocognitive impact of antiretroviral treatment.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21837444     DOI： 10.1007/s11904-011-0091-7

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN： 1548-3568            Impact factor:   5.071


  65 in total

1.  Cognitive performance of current methamphetamine and cocaine abusers.

Authors:  Sara L Simon; Catherine P Domier; Tiffanie Sim; Kimberly Richardson; Richard A Rawson; Walter Ling
Journal:  J Addict Dis       Date:  2002

2.  Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals.

Authors:  M A Cole; J B Margolick; C Cox; X Li; O A Selnes; E M Martin; J T Becker; H A Aronow; B Cohen; N Sacktor; E N Miller
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

Review 3.  The neuropsychology of HIV/AIDS in older adults.

Authors:  David J Hardy; David E Vance
Journal:  Neuropsychol Rev       Date:  2009-02-27       Impact factor: 7.444

4.  Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.

Authors:  E J Wright; B Grund; K Robertson; B J Brew; M Roediger; M P Bain; F Drummond; M J Vjecha; J Hoy; C Miller; A C Penalva de Oliveira; W Pumpradit; J C Shlay; W El-Sadr; R W Price
Journal:  Neurology       Date:  2010-08-11       Impact factor: 9.910

5.  Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.

Authors:  Patrick S Sullivan; Debra L Hanson; Eyasu H Teshale; Linda L Wotring; John T Brooks
Journal:  AIDS       Date:  2006-05-12       Impact factor: 4.177

6.  Prevalence of cognitive disorders differs as a function of age in HIV virus infection.

Authors:  James T Becker; Oscar L Lopez; Mary Amanda Dew; Howard J Aizenstein
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

7.  Cognitive functioning in younger and older HIV-1-infected adults.

Authors:  Frances L Wilkie; Karl Goodkin; Imad Khamis; Maria H van Zuilen; Diana Lee; Robert Lecusay; Mauricio Concha; Stephen Symes; Paola Suarez; Carl Eisdorfer
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

8.  Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study.

Authors:  Katie B Anderson; Jodie L Guest; David Rimland
Journal:  Clin Infect Dis       Date:  2004-10-25       Impact factor: 9.079

9.  Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.

Authors:  Cristina Mussini; Christian Manzardo; Margaret Johnson; Antonella d'Arminio Monforte; Caterina Uberti-Foppa; Andrea Antinori; M John Gill; Laura Sighinolfi; Vanni Borghi; Adriano Lazzarin; José M Miró; Caroline Sabin
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

10.  HCV coinfection associated with slower disease progression in HIV-infected former plasma donors naïve to ART.

Authors:  Xiaoyan Zhang; Jianqing Xu; Hong Peng; Yan Ma; Lifeng Han; Yuhua Ruan; Bing Su; Ning Wang; Yiming Shao
Journal:  PLoS One       Date:  2008-12-22       Impact factor: 3.240
View more
  9 in total

Review 1.  Humanized mouse models for HIV-1 infection of the CNS.

Authors:  Jenna B Honeycutt; Patricia A Sheridan; Glenn K Matsushima; J Victor Garcia
Journal:  J Neurovirol       Date:  2014-11-04       Impact factor: 2.643

Review 2.  Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis.

Authors:  Dionna W Williams; Eliseo A Eugenin; Tina M Calderon; Joan W Berman
Journal:  J Leukoc Biol       Date:  2012-01-06       Impact factor: 4.962

3.  Molecular and pathologic insights from latent HIV-1 infection in the human brain.

Authors:  Paula Desplats; Wilmar Dumaop; David Smith; Anthony Adame; Ian Everall; Scott Letendre; Ronald Ellis; Mariana Cherner; Igor Grant; Eliezer Masliah
Journal:  Neurology       Date:  2013-03-13       Impact factor: 9.910

4.  Neurological Complications in Controlled HIV Infection.

Authors:  Kate M Crossley; Bruce J Brew
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

5.  A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals.

Authors:  Thomas D Marcotte; Reena Deutsch; Benedict Daniel Michael; Donald Franklin; Debra Rosario Cookson; Ajay R Bharti; Igor Grant; Scott L Letendre
Journal:  J Neuroimmune Pharmacol       Date:  2013-10-08       Impact factor: 4.147

6.  Longitudinal 5-year prediction of cognitive impairment among men with HIV disease.

Authors:  Natalia L Oliveira; Edward H Kennedy; Ryan Tibshirani; Andrew Levine; Eileen Martin; Cynthia Munro; Ann B Ragin; Leah H Rubin; Ned Sacktor; Eric C Seaberg; Andrea Weinstein; James T Becker
Journal:  AIDS       Date:  2021-05-01       Impact factor: 4.177

7.  A machine learning approach for identifying amino acid signatures in the HIV env gene predictive of dementia.

Authors:  Alexander G Holman; Dana Gabuzda
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

Review 8.  The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review.

Authors:  Thomas M Gates; Lucette A Cysique
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

9.  Gene expression patterns associated with neurological disease in human HIV infection.

Authors:  Pietro Paolo Sanna; Vez Repunte-Canonigo; Eliezer Masliah; Celine Lefebvre
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.